Charity announces ‘historic’ investment in MND clinical drug trial

Sign up for our free Health Check email to receive exclusive analysis on the week in health Get our free Health Check email Get our free Health Check email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy A charity has announced a “historic” £2 million investment in what is said to be the UK’s biggest ever motor neurone disease clinical drug trial. “This is the largest single research investment MND Scotland has ever made and will help drive the next phase of this pioneering trial, ensuring equitable access to a clinical trial for people with MND. Together, we will make time count.” MND Scotland is the foundational funder of the clinical trial, which started recruiting in February 2020, as a result of the charity’s initial £1.5 million investment. Professor Suvankar Pal, MND-SMART co-lead, said: “MND-SMART has already transformed the MND clinical trial landscape in the UK; so far more than 500 people with MND across Scotland and the rest of the UK have given up their time to take part in this vital research to identify potential new treatments.